Jones Medical expanding thyroid treatment line with acquisition of Daniels Pharmaceuticals.
Executive Summary
JONES MEDICAL EXPANDING THYROID LINE WITH ACQUISITION OF DANIELS Pharmaceuticals through a merger with Daniels' parent company Galen Pharmaceuticals, Jones Medical announced July 30. The agreement, slated to close Aug. 31, will expand Jones Med's share of the thyroid hormone market with the acquisition of Daniels' Levoxyl (levothyroxine) for the treatment of hypothyroidism.